Molecular/JJ
basis/NN
of/IN
a/DT
multiple/JJ
lymphokine/NN
deficiency/NN
in/IN
a/DT
patient/NN
with/IN
severe/JJ
combined/JJ
immunodeficiency/NN
./.

We/PRP
have/VBP
previously/RB
reported/VBN
that/IN
the/DT
T/NN
lymphocytes/NNS
of/IN
a/DT
child/NN
with/IN
severe/JJ
combined/JJ
immunodeficiency/NN
are/VBP
defective/JJ
in/IN
the/DT
transcription/NN
of/IN
several/JJ
lymphokine/NN
genes/NNS
that/WDT
include/VBP
IL2/NN
,/,
IL3/NN
,/,
IL4/NN
,/,
and/CC
IL5/NN
,/,
which/WDT
encode/VBP
interleukins/NNS
2/CD
,/,
3/CD
,/,
4/CD
,/,
and/CC
5/CD
(/(
IL-2/NN
,/,
-3/CD
,/,
-4/CD
,/,
and/CC
-5/CD
)/)
./.
=====
To/TO
determine/VB
whether/IN
the/DT
defect/NN
in/IN
the/DT
patient/NN
's/POS
T/NN
lymphocytes/NNS
involved/VBD
a/DT
trans-acting/JJ
factor/NN
common/JJ
to/TO
the/DT
affected/VBN
lymphokine/NN
genes/NNS
,/,
we/PRP
examined/VBD
the/DT
ability/NN
of/IN
nuclear/JJ
factors/NNS
from/IN
the/DT
patient/NN
's/POS
T/NN
lymphocytes/NNS
to/TO
bind/VB
response/NN
elements/NNS
present/JJ
in/IN
the/DT
regulatory/JJ
region/NN
of/IN
IL2/NN
./.
=====
Nuclear/JJ
factor/NN
NF-kB/NN
,/,
activation/NN
protein/NN
1/CD
(/(
AP-1/NN
)/)
,/,
OCT-1/NN
,/,
and/CC
NF-IL-2B/NN
binding/NN
activity/NN
were/VBD
normal/JJ
./.
=====
In/IN
contrast/NN
,/,
the/DT
binding/NN
of/IN
the/DT
nuclear/JJ
factor/NN
of/IN
activated/VBN
T/NN
cells/NNS
(/(
NF-AT/NN
)/)
to/TO
its/PRP$
response/NN
element/NN
in/IN
the/DT
IL2/NN
enhancer/NN
and/CC
to/TO
an/DT
NF-AT-like/JJ
response/NN
element/NN
present/JJ
in/IN
the/DT
IL4/NN
enhancer/NN
was/VBD
abnormal/JJ
./.
=====
To/TO
ascertain/VB
whether/IN
the/DT
abnormal/JJ
NF-AT/NN
binding/NN
activity/NN
was/VBD
related/JJ
to/TO
an/DT
impaired/JJ
function/NN
,/,
we/PRP
transfected/VBD
patient/NN
and/CC
control/NN
T/NN
lymphocytes/NNS
with/IN
constructs/NNS
containing/VBG
the/DT
reporter/NN
gene/NN
encoding/JJ
chloramphenicol/NN
acetyl/NN
transferase/NN
(/(
CAT/NN
)/)
under/IN
the/DT
control/NN
of/IN
the/DT
entire/JJ
IL2/NN
regulatory/JJ
region/NN
or/CC
of/IN
multimers/NNS
of/IN
individual/JJ
enhancer/NN
sequences/NNS
./.
=====
CAT/NN
expression/NN
directed/VBN
by/IN
the/DT
IL2/NN
regulatory/JJ
region/NN
or/CC
by/IN
a/DT
multimer/NN
of/IN
the/DT
NF-AT-binding/JJ
site/NN
was/VBD
markedly/RB
lower/JJR
in/IN
the/DT
patient/NN
relative/JJ
to/TO
controls/NNS
./.
=====
In/IN
contrast/NN
,/,
CAT/NN
gene/NN
expression/NN
directed/VBN
by/IN
a/DT
multimer/NN
of/IN
the/DT
OCT-1/NN
proximal/NN
(/(
OCT-1p/NN
)/)
-binding/JJ
site/NN
was/VBD
equivalent/JJ
in/IN
patient/NN
and/CC
controls/NNS
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
an/DT
abnormality/NN
of/or/IN|CC
influencing/JJ
NF-AT/NN
may/MD
underlie/VB
the/DT
multiple/JJ
lymphokine/NN
deficiency/NN
in/IN
this/DT
patient/NN
./.